Acepodia to Present Preclinical Data on its Gamma Delta T cell Therapy Candidate, ACE1831, at 2022 SITC Annual Meeting ...Middle East

ALAMEDA, Calif., and TAIPEI, Nov. 3, 2022 /PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique antibody-cell conjugation (ACC) technology to address gaps in cancer care, today announced the upcoming poster presentation...

Hence then, the article about acepodia to present preclinical data on its gamma delta t cell therapy candidate ace1831 at 2022 sitc annual meeting was published today ( Thursday 03/11/2022 - 10:52 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Acepodia to Present Preclinical Data on its Gamma Delta T cell Therapy Candidate, ACE1831, at 2022 SITC Annual Meeting )

Also on site :

• INCERGO S.A. PROGRESSION DE LA FUSION AVEC VISUAL SEMICONDUCTOR PAR L'ÉMISSION D'ACTIONS ET PRÉSENTATION D'ÉCRANS 3D SANS LUNETTE AU SALON DE L'ÉLECTRONIQUE GRAND PUBLIC DE LAS VEGAS
• Russia’s Sanctioned LNG Finds a Growing Market in China
• Big Tree Cloud Holdings Limited Announces AI Business Expansion, Key Management Appointments and Changes